Enhancing Healing of Chronic Wounds via Novel Bioengineered Growth Factor Scaffold (DOI 10.1111/wrr.70089)
Summary: A recent experimental study in Wound Repair & Regeneration investigates a bioengineered scaffold designed to deliver growth factors over an extended period, aiming to support healing in chronic or refractory wounds. The scaffold combines biomaterials engineered for sustained release with growth factors known to enhance angiogenesis and epithelial cell proliferation. Comparative in vivo tests demonstrate accelerated closure and enhanced vascular density in treated wounds compared to standard care controls.
Key Highlights:
- The scaffold material is designed for biocompatibility and controlled degradation, allowing gradual growth factor release over multiple weeks.
- In vivo models (rodent chronic wounds) showed not only faster wound closure but also superior quality of the regenerated tissue—denser capillary networks and better epidermal thickness / integrity.
- Histologic analysis indicated reduced inflammatory infiltration and improved collagen architecture in scaffold-treated wounds.
- The study underscores that combining biomaterial scaffolds with growth factor delivery may overcome limitations of growth factor therapies alone, such as rapid diffusion/degradation and inconsistent retention at wound sites.
Read the full article in Wound Repair & Regeneration
Keywords:
bioengineered scaffold,
growth factor delivery,
chronic wound,
angiogenesis,
controlled release